Аннотация
При сравнении результатов выполнения ТМЛР в сочетании с ангиогенным фактором
Литература
1. Бокерия Л. А., Беришвили И. И., von Specht B.-U. и др. ТМЛР в сочетании с ангиогенными факторами: 6 месяцев после операции // Бюлл. НЦССХ им. А. Н. Бакулева РАМН. - 2006. - Т. 7, № 3. - С. 44.
2. Atluri P., Panlilio C. M., Liao G. P. et al. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135, № 2. - P. 283-290.
3. Bockeria L., Berishvili I. Transmyocardial laser revascularization: 10-year experience. Abstracts 56- th ESCVS Meeting // Interact. Cardiovasc. Thorac. Surg. - 2007. - Vol. 6 (Suppl. 1). - P. S53.
4. Bokeria L. A., Berishvili I. I., Sigaev U. I. et al. Is transmyocardial laser revascularization of for patients with end-stage coronary artery disease? Abstracts // Ibid. - 2006. - Vol. 5 (Suppl. 1). - P. 07-8, S45.
5. Celletti F. L., Waugh J. M., Amabile P. G. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression // Nat. Med. - 2001. - Vol. 7. - P. 425-429.
6. Chu V., Kuang J. Q., McGinn A. et al. Angiogenic response induced by mechanical transmyocardial revascularization // J. Thorac. Cardiovasc. Surg. - 1999. - Vol. 118. - P. 849-856.
7. De Muinck E., Simons M. Re-evaluating neovascularization // J. Mol. Cell. Cardiol. - 2004. - Vol. 36. - P. 25-32.
8. Domkowski P., Biswas S., Steenbergen C. et al. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization // Circulation. - 2001. - Vol. 103. - P. 469-471.
9. Dor Y., Djonov V., Abramovitch R. et al. Conditional switching of VEGF provides new insights into adult neovascularizadon and pro-angiogenic therapy // EMBO J. - 2002. - Vol. 21. - P. 1939-1947.
10. Dzau V. J., Mann M. J., Ehsan A., Gries D. P. Gene therapy and genomic strategies for cardiovascular surgery: the emergine field of surgiomics // J. Thorac. Cardiovasc. Surg. - 2001. - Vol. 121. - P. 206-216.
11. Fleisher K. J., Goldsmith-Clermont P. J., Fonger J. D. et al. One-month response of transmyocardial laser channels with molecular intervention // Ann. Thorac. Surg. - 1996. - Vol. 62. - P. 1051-1058
12. Gao Y., Lecker S., Post M. J. et al. Inhibition of ubiquitin- proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide // J. Clin. Invest. - 2000. - Vol. 106. - P. 439-448.
13. Geist A., Marx J., Muller S. et al. Combination of enoxeparin and Fibroblast growth factor-1 in creases myocardial blood flogs and capillary density after myocardial infarction in rebbits // Eur. Surg. Research. - 2005. - Vol. 37. - P. 191-198.
14. Hedman M. et al. Safety and feasibility of catheterbased local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and instent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) // Circulation. - 2003. - Vol. 107. - P. 2677-2683.
15. Heilmann C. A. U., Attmann T., von Samson P. et al. Transmyocardial laser revascularization combined with vascular endothelial growth factor (VEGF 121) gene therapy for chronic myocardial ischemia - do the effects really add up? // Eur. J. Cardiothorac. Surg. - 2003. - Vol. 23. - P. 74-80.
16. Henry T., Annex B., Azrin M. et al. Final results of the VIVA trial of rhVEGF human therapeutic angiogenesis // Circulation. - 2003. - Vol. 107. - P. 1359-1365.
17. Hughes G. C., Biswas S. S., Yin B., Coleman R. E. et al. Therapeuthic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF // Ann. Thorac. Surg. - 2004. - Vol. 77. - P. 812-818.
18. Kawasuji M., Nagamine, Ikeda M. et al. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor // Ibid. - 2000. - Vol. 69. - P. 1155-1161
19. Khurana R., Simons M. Insights from Angiogenesis Trials Using Fibroblast Growth Factor for Advanced Arteriosclerotic Disease // Trends Cardiovasc. Med. - 2003. - Vol. 13. - P. 116-122.
20. Laham R. J., Sellke F. W., Edelman E. R. et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial // Circulation. - 1999. - Vol. 100. - P. 1865-1871.
21. Liu Y., Sun L., Huan Y. et al. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analisys with dobutamine cardiovascular magnetic resonance tagging // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 30. - P. 103-108.
22. Losordo D. W., Vale P. R., Symes J. F. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of ph VEGF165 as sole therapy for myocardial ischemia // Circulation. - 1998. - Vol. 98. - P. 2800-2804.
23. Lutter G., Attmann T., Heilmann C., Samson P. The combined use transmiocardial laser revascularization and fibroblastic growth factor enhances perfusion and regional contractility in chronically ischemic porcine hearts // Eur. J. Cardiothorac. Surg. - 2002. - Vol. 22. - P. 753-761.
24. Mueller X. M., Tevaearai H. T., Genton C. Y. et al. Are there vascular density gradients along myocardial laser channels? // Ann. Thorac. Surg. - 1999. - Vol. 68. - P. 125-130.
25. Pelletier M. P., Giaid A., Sivaraman S. et al. Angiogenesis and growth factor expression in model of transmyocardial revascularization // Ibid. - 1998. - Vol. 66, № 1. - P. 12-18.
26. Post M., Simons M. The rational phase of therapeutic angiogenesis // Minerva Cardioangiol. - 2003. - Vol. 51. - P. 421-432.
27. Rak J., Weitz J. J. Heparin and angiogenesis, size maters // Arterioscler. Thromb. Vasc. - 2003. - Vol. 23. - P. 1954-1955.
28. Rosengart T., Lee L., Patel S. et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease // Circulation. - 1999. - Vol. 100. - P. 468-474.
29. Rosengart T., Patel S., Crystal R. Therapeutic angiogenesis: protein and gene therapy delivery strategies // J. Cardiovasc. Risk. - 1999. - Vol. 6. - P. 29-40.
30. Sakakibara Y., Tambara K., Sakaguchi G. et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor // Eur. J. Cardiothorac. Surg. - 2003. - Vol. 24. - P. 105-112.
31. Sayeed-Shah U., Mann M. J., Martin J. еt al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with trasmyocardial laser revascularization // J. Thorac. Cardiovasc. Surg. - 1998. - Vol. 116. - P. 763-769.
32. Sellke F., Laham R., Edelman E. et al. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results // Ann. Thorac. Surg. - 1998. - Vol. 65. - P. 1540-1544.
33. Sellke F. W., Ruel M. Vascular growth factors and angiogenesis in cardiac surgery // Ibid. - 2003. - Vol. 75. - P. S685-690.
34. Semenza G. L. Signal transduction to hypoxiainducible factor 1 // Biochem. Pharmacol. - 2002. - Vol. 64. - P. 993-998.
35. Shumacher B., Pecher P, von Specht B.-U., Stregman T. Induction of neo-angiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary disease // Circulation. - 1998. - Vol. 97, № 7. - P. 645-650.
